"Personalità e Sclerosi Multipla: il ruolo dello Psicologo Clinico nella reazione alla malattia" S. Costanzo

"Personalità e Sclerosi Multipla: il ruolo dello Psicologo Clinico nella reazione alla malattia" S. Costanzo

Articolo scientifico "Personalità e Sclerosi Multipla: il ruolo dello Psicologo Clinico nella reazione alla malattia" - S. Costanzo, pubblicato sulla Rivista Psicopuglia di Dic. 2018

psicopuglia dic 2018.pdf

Articolo scientifico "Personalità e Sclerosi Multipla: il ruolo dello Psicologo Clinico nella reazione alla malattia" - S. Costanzo,pubblicato sulla Rivista Psicopuglia di Dic. 2018. 

Ulteriori informazioni  
“Genitori ancora bambini. Indagine sulla genitorialità precoce”

“Genitori ancora bambini. Indagine sulla genitorialità precoce”

“Genitori ancora bambini. Indagine sulla genitorialità precoce”, (2017) I. Vivoli, M. Carone & S. Costanzo. Articolo scientifico e di ricerca pubblicato su “Psicopuglia" Vol 20, Dic. 2017.tenuti/argomenti dell'articolo sul tuo sito web.

pubblicazione psicopuglia dic 2017.pdf

Genitori ancora bambini. Indagine sulla genitorialità precoce”, (2017) I. Vivoli, M. Carone & S. Costanzo. 

Articolo scientifico e di ricerca pubblicato su  “Psicopuglia" Vol 20, Dic. 2017.

Ulteriori informazioni  
Oncological Genetic Counseling (OGC) for high-risk hereditary cancer: what can HADs tell US?.

Oncological Genetic Counseling (OGC) for high-risk hereditary cancer: what can HADs tell US?.

Con orgoglio e grande soddisfazione, è finalmente online su una rivista internazionale di mediciba e oncologia una mia pubblicazione a primo nome.

Ulteriori informazioni  
Spectrum of Germline Pathogenic Variants in BRCA1/2 Genes in the Apulian Southern Italy Population: Geographic Distribution and Evidence for Targeted Genetic Testing Margherita Patruno, Simona De Summa, Nicoletta Resta, Mariapia Caputo, Silvia Costanzo, Maria Digennaro, Brunella Pilato, Rosanna Bagnulo, Antonino Pantaleo, Cristiano Simone, Maria Iole Natalicchio, Elisabetta De Matteis, Paolo Tarantino, Stefania Tommasi, Angelo Paradiso

Spectrum of Germline Pathogenic Variants in BRCA1/2 Genes in the Apulian Southern Italy Population: Geographic Distribution and Evidence for Targeted Genetic Testing Margherita Patruno, Simona De Summa, Nicoletta Resta, Mariapia Caputo, Silvia Costanzo, Maria Digennaro, Brunella Pilato, Rosanna Bagnulo, Antonino Pantaleo, Cristiano Simone, Maria Iole Natalicchio, Elisabetta De Matteis, Paolo Tarantino, Stefania Tommasi, Angelo Paradiso

Spectrum of Germline Pathogenic Variants in BRCA1/2 Genes in the Apulian Southern Italy Population: Geographic Distribution and Evidence for Targeted Genetic Testing Margherita Patruno 1, Simona De Summa 2, Nicoletta Resta 3, Mariapia Caputo 2, Silvia Costanzo 1, Maria Digennaro 1, Brunella Pilato 2, Rosanna Bagnulo 3, Antonino Pantaleo 3, Cristiano Simone 3 4, Maria Iole Natalicchio 5, Elisabetta De Matteis 6, Paolo Tarantino 7, Stefania Tommasi 2, Angelo Paradiso 1 BRCA1/2-associated hereditary breast and ovarian cancer is the most common form of hereditary breast and ovarian cancer and occurs in all ethnicities and racial populations. Different BRCA1/BRCA2 pathogenic variants (PVs) have been reported with a wide variety among populations. In this study, we retrospectively analyzed prevalence and geographic distribution of pathogenic germline BRCA1/2 variants in families from Apulia in southern Italy and evaluated the genotype–phenotype correlations. Data were collected from Oncogenetic Services present in Apulian hospitals and a shared database was built containing Apulian native probands (n = 2026) that had undergone genetic testing from 2004 to 2019. PVs were detected in 499 of 2026 (24.6%) probands and 68.5% of them (342 of 499) were in the BRCA1 gene. We found 65 different PVs in BRCA1 and 46 in BRCA2. There were 10 most recurrent PVs and their geographical distribution appears to be significantly specific for each province. We have assumed that these PVs are related to the historical and geopolitical changes that occurred in Apulia over time and/or to a “founder effect”. Broader knowledge of BRCA1/2 prevalence and recurring PVs in specific geographic areas could help establish more flexible genetic testing strategies that may enhance our ability to detect high-risk subjects. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467705/

Ulteriori informazioni  
Receptive music therapy versus group music therapy with breast cancer patients hospitalized for surgery  Fulvia Lagattolla, Barbara Zanchi, Milella Pietro, Claudia Cormio, Vito Lorusso, Sergio Diotaiuti, Annarita Fanizzi, Raffaella Massafra, Silvia Costanzo, Francesca Caporale, Erika Rieti & Francesca Romito

Receptive music therapy versus group music therapy with breast cancer patients hospitalized for surgery Fulvia Lagattolla, Barbara Zanchi, Milella Pietro, Claudia Cormio, Vito Lorusso, Sergio Diotaiuti, Annarita Fanizzi, Raffaella Massafra, Silvia Costanzo, Francesca Caporale, Erika Rieti & Francesca Romito

Receptive music therapy versus group music therapy with breast cancer patients hospitalized for surgery Fulvia Lagattolla,1 Barbara Zanchi,2 Milella Pietro,1,3 Claudia Cormio,1 Vito Lorusso,4 Sergio Diotaiuti,5 Annarita Fanizzi,6 Raffaella Massafra,6 Silvia Costanzo,corresponding author7 Francesca Caporale,1 Erika Rieti,1 and Francesca Romito1

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924845/

Abstract

Hospitalization for breast surgery is a distressing experience for women. This study investigated the impact of music therapy (MT), an integrative approach that is characterized by the establishment of a therapeutic relationship between patients and a certified music therapist, through different musical interventions targeted to the specific needs of the patients. The impact of two different MT experiences was compared on anxiety and distressing emotions.Methods: One hundred fifty-one patients during hospitalization for breast surgery were randomly assigned to two music therapy treatment arms: individual/receptive (MTri) vs. group/active-receptive integrated (MTiGrp). Stress, depression, anger, and need for help were measured with the emotion thermometers (ET) and State Trait Anxiety Inventory Y-1 form (STAY-Y1). Data were collected before and after the MT intervention.Results: Both types of MT interventions were effective in reducing all the variables: stress, depression, anger, and anxiety (T Student p‹0.01). Patients' perception of help received was correlated with a significant reduction in anxiety and distressing emotions during hospitalization for breast surgery.Conclusion: Considerations regarding the implementation of MT interventions in clinical practice are discussed. In individual receptive MT, there was a significant decrease in anxiety levels, whereas in the integrated MT group, there was a higher perception of help received and use of inter-individual resources.Keywords: Breast cancer; Emotion thermometers; Group music therapy; Psychological distress.© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.PubMed Disclaimer

Ulteriori informazioni  
Remote vs in-person BRCA1/2 non-carriers test disclosure: patients’ choice during Covid-19 pandemic restriction

Remote vs in-person BRCA1/2 non-carriers test disclosure: patients’ choice during Covid-19 pandemic restriction

Remote vs in-person BRCA1/2 non-carriers test disclosure: patients’ choice during Covid-19 pandemic restriction Silvia Costanzo, Simona De Summa, Leonarda Maurmo, Maria Digennaro, Margherita Patruno & Angelo Paradiso

https://link.springer.com/article/10.1007/s10689-022-00307-y


During Covid-19 pandemic most hospitals have restricted in-person delivery of non-essential healthcare services, including genetic testing delivery, to slow the spread of the virus. Our Onco-Genetic Service also faced this challenging period and had to re-organize its clinical practice with the use of tele-health. Aim of the present paper is to understand whether and how Covid-19-related changes in medical practice influenced patients’ satisfaction about the health service provided. 125 BRCA1/2 non carriers (109/125, 87.2% female and 16/125, 12.8% male) in Istituto Tumori “Giovanni Paolo II” of Bari were enrolled. All participants were asked to choose whether they prefer in-person or remote post-test counselling session. Basing on patients’ choice, two groups of subjects were composed. One week after the post-test counselling session, participants were phone called and asked to complete: a socio-demographic form, a brief structured interview about their Covid-19 related worries and their satisfaction with the health service provided, Hospital Anxiety and Depression Scale and Fear of Covid-19 scale. Qualitative information about patients’ choice were also collected. No significant difference about patients’ satisfaction with the health service provided emerged between groups. Patients who preferred remote post-test counselling had higher anxiety, worries and fear-of Covid-19 than the others. All remote-counselling subjects preferred tele-genetics because of Covid-19 security, would choose it again and would recommend it to others. Cancer tele-genetics offers good guarantees of comfort and efficacy, but patients’ choices are related to personal and psychological variables. The use of tele-genetics has to be a patient’s choice.

Ulteriori informazioni